{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T09:57:22Z","timestamp":1794391042022,"version":"4.9.0"},"publisher-location":"Boston, MA","reference-count":24,"publisher":"Springer US","isbn-type":[{"value":"9781461378266","type":"print"},{"value":"9781461561651","type":"electronic"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1997]]},"DOI":"10.1007\/978-1-4615-6165-1_10","type":"book-chapter","created":{"date-parts":[[2011,7,4]],"date-time":"2011-07-04T02:04:53Z","timestamp":1309745093000},"page":"203-211","source":"Crossref","is-referenced-by-count":6,"title":["Classification, staging, and management of non-Hodgkin\u2019s lymphomas"],"prefix":"10.1007","author":[{"given":"Paul F.","family":"Mansfield","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly K.","family":"Hunt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"10_CR1","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1182\/blood.V84.5.1361.1361","volume":"84","author":"NL Harris","year":"1994","unstructured":"Harris NL, Jaffe ES, Stein H, Banks PM, Chan JKC, Cleary ML, Delsol G, De Wolf-Peeters C, Falini B, Gatter KC, Grogan TM, Isaacson PG, Knowles DM, Mason DY, Muller-Hermelink H-K, Pileri SA, Piris MA, Ralfkiaer E, Warnke RA. A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood 84: 1361\u20131392, 1994.","journal-title":"Blood"},{"key":"10_CR2","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1002\/1097-0142(19820515)49:10<2112::AID-CNCR2820491024>3.0.CO;2-2","volume":"49","author":"The Non-Hodgkins Lymphoma Pathologic Classification Project","year":"1982","unstructured":"The Non-Hodgkin\u2019s Lymphoma Pathologic Classification Project. National Cancer Institute sponsored study of classifications of Non-Hodgkin\u2019s lymphomas. Summary and description of a Working Formulation for clinical usage. Cancer 49: 2112\u20132135, 1982.","journal-title":"Cancer"},{"key":"10_CR3","first-page":"1","volume":"9","author":"DL Longo","year":"1995","unstructured":"Longo DL. The REAL classification of lymphoid neoplasms: One clinician\u2019s view. Principles Pract Oncol Update 9: 1\u201312, 1995.","journal-title":"Principles Pract Oncol Update"},{"key":"10_CR4","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJM199309303291402","volume":"329","author":"The International Non-Hodgkins Lymphoma Prognostic Factors Project","year":"1993","unstructured":"The International Non-Hodgkin\u2019s Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodgkin\u2019s lymphoma. N Engl J Med 329: 987\u2013994, 1993.","journal-title":"N Engl J Med"},{"key":"10_CR5","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1200\/JCO.1994.12.7.1343","volume":"12","author":"A L\u00f6pez-Guillermo","year":"1994","unstructured":"L\u00f6pez-Guillermo A, Montserrat E, Bosch F, Terol M, Campo E, Rozman C. Applicability of the international index for aggressive lymphomas to patients with low-grade lymphoma. J Clin Oncol 12: 1343\u20131348, 1994.","journal-title":"J Clin Oncol"},{"key":"10_CR6","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1093\/oxfordjournals.annonc.a058324","volume":"3","author":"J Rodriguez","year":"1992","unstructured":"Rodriguez J, Cabanillas F, McLaughlin P, Swan F, Rodriguez M, Hagemeister F, Romaguera J. A proposal for a simple staging system for intermediate grade lymphoma and immuno-blastic lymphoma based on the \u2018tumor score.\u2019 Ann Oncol 3: 711\u2013717, 1992.","journal-title":"Ann Oncol"},{"key":"10_CR7","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1002\/1097-0142(19831015)52:8<1410::AID-CNCR2820520813>3.0.CO;2-3","volume":"52","author":"P Isaacson","year":"1983","unstructured":"Isaacson P, Wright DH. Malignant lymphoma of mucosa-associated lymphoid tissue: A distinctive type of B-cell lymphoma. Cancer 52: 1410\u20131416, 1983.","journal-title":"Cancer"},{"key":"10_CR8","first-page":"1273","volume":"1","author":"JR Warren","year":"1983","unstructured":"Warren JR, Marshall B. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1: 1273\u20131275, 1983.","journal-title":"Lancet"},{"key":"10_CR9","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/0016-5085(92)91723-H","volume":"102","author":"T Radaszkiewicz","year":"1992","unstructured":"Radaszkiewicz T, Dragosics B, Bauer P. Gastrointestinal malignant lymphomas of the mucosa-associated lymphoid tissue: Factors relevant to prognosis. Gastroenterology 102: 1628\u20131638, 1992.","journal-title":"Gastroenterology"},{"key":"10_CR10","doi-asserted-by":"crossref","first-page":"767","DOI":"10.7326\/0003-4819-122-10-199505150-00006","volume":"122","author":"E Roggero","year":"1995","unstructured":"Roggero E, Zucca E, Pinotti G, Pascarella A, Capella C, Savio A, Pedrinis E, Paterlini A, Venco A, Cavalli F. Eradication of Helicobacter pylori infection in primary low-grade gastric lymphoma of mucosa-associated lymphoid tissue. Ann Intern Med 122: 767\u2013769, 1995.","journal-title":"Ann Intern Med"},{"key":"10_CR11","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1016\/S0140-6736(95)90113-2","volume":"345","author":"E Bayerd\u00f6rffer","year":"1995","unstructured":"Bayerd\u00f6rffer E, Neubauer A, Rudolph B, Thiede C, Lehn N, Eidt S, Stolte M, for the MALT Lymphoma Study Group. Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. Lancet 345: 1591\u20131594, 1995.","journal-title":"Lancet"},{"key":"10_CR12","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/S0140-6736(95)90195-7","volume":"345","author":"G Cammarota","year":"1995","unstructured":"Cammarota G, Montalto M, Tursi A, Vecchio FM, Fedeli G, Gasbarrini G. Helicobacter pylori reinfection and rapid relapse of low-grade B-cell gastric lymphoma. Lancet 345: 192, 1995.","journal-title":"Lancet"},{"key":"10_CR13","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1056\/NEJM199405053301803","volume":"330","author":"J Parsonnet","year":"1994","unstructured":"Parsonnet J, Hansen S, Rodriguez L, Gelb AB, Warnke R, Jellum E, Orentreich N, Vogelman JH, Friedman GD. Helicobacter pylori infection and gastric lymphoma. N Engl J Med 330: 1267\u20131271, 1994.","journal-title":"N Engl J Med"},{"key":"10_CR14","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1056\/NEJM199405053301812","volume":"330","author":"PG Isaacson","year":"1994","unstructured":"Isaacson PG. Gastric lymphoma and Helicobacter pylori. N Engl J Med 330: 1310\u20131311, 1994.","journal-title":"N Engl J Med"},{"key":"10_CR15","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/0140-6736(93)91408-E","volume":"342","author":"T Hussell","year":"1993","unstructured":"Hussell T, Isaacson PG, Crabtree JE, Spencer J. The response of cells from low-grade B-cell gastric lymphomas of mucosa-associated lymphoid tissue to Helicobacter pylori. Lancet 342: 571\u2013574, 1993.","journal-title":"Lancet"},{"key":"10_CR16","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/S0140-6736(94)91496-6","volume":"343","author":"T Azuma","year":"1994","unstructured":"Azuma T, Konishi J, Tanaka Y, Hirai M, Ito S, Kato T, Kohli Y. Contribution of HLA-DQA gene to host\u2019s response against Helicobacter pylori. Lancet 343: 542\u2013543, 1994.","journal-title":"Lancet"},{"key":"10_CR17","unstructured":"Yahanda A, Mansfield P. The role of locoregional therapy in the treatment of stage IE and HE gastric lymphoma (abstr). Proceedings of the Society of Surgical Oncology, 47th Annual Cancer Symposium, 1994, p. 19."},{"key":"10_CR18","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1097\/00000478-199207000-00001","volume":"16","author":"PM Banks","year":"1992","unstructured":"Banks PM, Chan J, Cleary ML, Delsol G, De Wolf-Peeters C, Gatter K, Grogan TM, Harris NL, Isaacson PG, Jaffe ES, Mason D, Pileri S, Ralfkiaer E, Stein H, Warnke RA. Mantle cell lymphoma: A proposal for unification of morphologic, immunologic, and molecular data. Am J Surg Pathol 16: 637\u2013640, 1992.","journal-title":"Am J Surg Pathol"},{"key":"10_CR19","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1182\/blood.V85.4.1075.bloodjournal8541075","volume":"85","author":"RI Fisher","year":"1995","unstructured":"Fisher RI, Dahlberg S, Nathwani BN, Banks PM, Miller TP, Grogan TM. A clinical analysis of two indolent lymphoma entities: Mantle cell lymphoma and marginal zone lymphoma (including the mucosa-associated lymphoid tissue and monocytoid B-cell subcategories): A Southwest Oncology Group study. Blood 85: 1075\u20131082, 1995.","journal-title":"Blood"},{"key":"10_CR20","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/oxfordjournals.annonc.a059156","volume":"6","author":"DA Stewart","year":"1995","unstructured":"Stewart DA, Vose JM, Weisenburger DD, Anderson JR, Ruby El, Bast MA, Bierman PJ, Kessinger A, Armitage JO. The role of high-dose therapy and autologous hematopoietic stem cell transplantation for mantle cell lymphoma. Ann Oncol 6: 263\u2013266, 1995.","journal-title":"Ann Oncol"},{"key":"10_CR21","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1056\/NEJM199304083281404","volume":"328","author":"RI Fisher","year":"1993","unstructured":"Fisher RI, Gaynor ER, Dahlberg S, Oken MM, Grogan TM, Mize EM, Glick JH, Coltman CA, Miller TP. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin\u2019s lymphoma. N Engl J Med 328: 1002\u20131006, 1993.","journal-title":"N Engl J Med"},{"key":"10_CR22","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1182\/blood.V71.1.117.117","volume":"71","author":"WS Velasquez","year":"1988","unstructured":"Velasquez WS, Cabanillas F, Salvador P, McLaughlin P, Fridrik M, Tucker S, Jagannath S, Hagemeister FB, Redman JR, Swan F, Barlogie B. Effective salvage therapy for lymphoma with cisplatin in combination with high-dose ara-C and dexamethasone (DHAP). Blood 71: 117\u2013122, 1988.","journal-title":"Blood"},{"key":"10_CR23","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1056\/NEJM199512073332305","volume":"333","author":"T Philip","year":"1995","unstructured":"Philip T, Guglielmi C, Hagenbeek A, Somers R, Van Der Lelie H, Bron D, Sonneveld P, Gisselbrecht C, Cahn J-Y, Harousseau J-L, Coiffier B, Biron P, Mandelli F, Chauvin F. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin\u2019s lymphoma. N Engl J Med 333: 1540\u20131545, 1995.","journal-title":"N Engl J Med"},{"key":"10_CR24","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1056\/NEJM199512073332312","volume":"333","author":"JM Vose","year":"1995","unstructured":"Vose JM. Treatment for non-Hodgkin\u2019s lymphoma in relapse. N Engl J Med 333: 1565\u20131566, 1995.","journal-title":"N Engl J Med"}],"container-title":["Cancer Treatment and Research","Surgical Oncology"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4615-6165-1_10.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,18]],"date-time":"2020-11-18T01:53:00Z","timestamp":1605664380000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4615-6165-1_10"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997]]},"ISBN":["9781461378266","9781461561651"],"references-count":24,"URL":"https:\/\/doi.org\/10.1007\/978-1-4615-6165-1_10","relation":{"is-part-of":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1007\/978-1-4615-6165-1","asserted-by":"object"}]},"ISSN":["0927-3042"],"issn-type":[{"value":"0927-3042","type":"print"}],"subject":[],"published":{"date-parts":[[1997]]}}}